Neurostimulation Devices Market Industry Analysis, Regional Data, Growth, Trends, Demand, and Forecasts 2027

Emergen Research Logo

Emergen Research Logo

Neurostimulation Devices Market Size โ€“ USD 5.60 billion in 2019, Market Growth - CAGR of 12.6%

The increasing prevalence of chronic nervous disorders and rising demand for minimally invasive surgeries is driving the demand of the market.”
— Emergen Research

VANCOUER, BC, CANADA, May 19, 2022 /EINPresswire.com/ -- The Global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to the latest analysis by Emergen Research. The growth of this market can be attributed to the growing incidences of health disorders due to unhealthy lifestyle habits and is expected to drive the growth of the neurostimulation devices market.

The high cost of neurostimulation devices and the presence of alternative therapeutic procedures is likely to hamper the demand for neurostimulation devices over the forecast period. Adverse effects and risks pertaining to the use of neurostimulation devices, such as allergic reactions or prickling of skin, might restrict the utilization of neurostimulation devices. Moreover, stringent government regulations on device approval might act as a barrier to the growth of the market.

๐’๐จ๐ฆ๐ž ๐ฆ๐š๐ฃ๐จ๐ซ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž Bayer AG, Johnson & Johnson, AstraZeneca PLC, Pfizer Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Amgen Inc., Merck & Co. Inc., AbbVie Inc., and Novartis AG, among others.

๐†๐ž๐ญ ๐…๐‘๐„๐„ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐ฐ๐ข๐ญ๐ก ๐“๐Ž๐‚ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ญ๐ก๐ž ๐ฌ๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.emergenresearch.com/request-sample-form/349

The growth of neurostimulation devices is expected to be driven by increased demand for minimally invasive surgeries due to the increasing preference among patients and doctors for faster recovery and shorter hospital stays. Demand for neurostimulation devices is most likely to be motivated by the growing prevalence of neurological disorders, such as epilepsy, dystonia and Parkinson's disease.

๐๐ž๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ : ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž :

The prominent players operating in the Neurostimulation Devices Market are profiled in-depth in the report and their strategies, collaborations, and product innovations. The analysis of the key players and their strategies to fortify their presence in the market impart a better understanding of the competitive landscape of the Electronic Health Records Market.

๐’๐จ๐ฆ๐ž ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐…๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ :

In 2019, Medtronic launched the Intellis platform for the management of certain types of chronic intractable pain. The platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow. It can track patients 24/7 and help in monitoring chronic pain.

Deep brain stimulators held the second largest market share of 19.8% in 2019. The rising incidence of neurological disorders among the rising global geriatric population is expected to boost the demand for Deep brain stimulators.

Urinary and fecal Incontinence is expected to register steady growth over the forecast period. Increasing utilization of the sacral nerve stimulators for the treatment of Urinary and fecal Incontinence is expected to drive the growth of the neurostimulation devices market.

North America accounted for the largest market share of the Neurostimulation Devices market in 2019 due to the improved healthcare system and government funding for the research and development of neurostimulation devices.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐„๐ง๐ญ๐ข๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฉ๐š๐œ๐ค๐ž๐ ๐ฐ๐ข๐ญ๐ก ๐“๐Ž๐‚, ๐“๐š๐›๐ฅ๐ž๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐š๐ง๐ ๐Ž๐ฎ๐ญ๐ฅ๐ข๐ง๐ž ๐จ๐Ÿ ๐๐ซ๐จ๐ฆ๐ข๐ง๐ž๐ง๐ญ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ @ https://www.emergenresearch.com/industry-report/neurostimulation-devices-market

The Asia Pacific region is expected to be the fastest-growing region over the forecast period. The economic development and increasing Healthcare Budgetary Allocation in developing countries is expected to drive the growth of neurostimulation devices in the region.

๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ž๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง :

๐„๐ฆ๐ž๐ซ๐ ๐ž๐ง ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ก๐š๐ฌ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐๐ž๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐จ๐ง ๐ญ๐ก๐ž ๐›๐š๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ, ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง, ๐š๐ง๐ ๐ซ๐ž๐ ๐ข๐จ๐ง:

๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•)

Sacral Nerve stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulators
Deep Brain Stimulators

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ•)

Epilepsy

Depression

Dystonia

Gastroparesis

Pain management

Urinary and Fecal Incontinence

Essential Tremor

Parkinsonโ€™s Disease

Others

๐๐ž๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐š๐ง๐ ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง @ https://www.emergenresearch.com/request-for-customization/349

๐†๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐œ๐š๐ฅ๐ฅ๐ฒ, ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐ก๐ž ๐ค๐ž๐ฒ ๐ซ๐ž๐ ๐ข๐จ๐ง๐ฌ, ๐Ÿ๐จ๐œ๐ฎ๐ฌ๐ž๐ฌ ๐จ๐ง ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ ๐ฌ๐š๐ฅ๐ž๐ฌ, ๐ฏ๐š๐ฅ๐ฎ๐ž, ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ก๐š๐ซ๐ž ๐š๐ง๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐ข๐ง ๐ญ๐ก๐ž๐ฌ๐ž ๐ซ๐ž๐ ๐ข๐จ๐ง๐ฌ, ๐œ๐จ๐ฏ๐ž๐ซ๐ข๐ง๐ :

United States

Europe

China

Japan

Southeast Asia

India

๐–๐ž ๐œ๐š๐ง ๐š๐ฅ๐ฌ๐จ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐ฌ๐ž๐ฉ๐š๐ซ๐š๐ญ๐ž ๐ซ๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐จ๐ซ ๐œ๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐ฅ๐ž๐ฏ๐ž๐ฅ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ, ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ซ๐ž๐ ๐ข๐จ๐ง๐ฌ:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

๐–๐ก๐ฒ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ž๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ?

The study paper dissects the total market potential of major regions with strengths, opportunity and challenge, constraints, and dangers.

By identifying the high-improvement locations, the study inspects the open entryways, keeping an eye out for accomplices.

It examines each submarket in terms of a single improvement design and its contribution to the market.

It examines the recent developments, such as advancements, business strategies, new product releases, and acquisitions.

It purposefully profiles the major market players and thoroughly investigates their advancement strategies.

๐“๐š๐ค๐ž ๐š ๐‹๐จ๐จ๐ค ๐š๐ญ ๐จ๐ฎ๐ซ ๐จ๐ญ๐ก๐ž๐ซ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

intelligent drug discovery market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/intelligent-drug-discovery-market

digital biomarkers market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/digital-biomarkers-market

medical devices testing services market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/medical-devices-testing-services-market

human microbiome modulators market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market

medical supplies market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/medical-supplies-market

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

The global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to a current analysis by Emergen Research